Table 1 Baseline characteristics in patients with cholangiocarcinoma (n = 120).
From: Prognostic value of preoperative serum ferritin in cholangiocarcinoma patients
Variables | Values | Total(n) | Percent(%) |
|---|---|---|---|
Clinicopathological factors | |||
Age (years) | ≤ 60/>60 | 55/65 | 45.8/54.2 |
Gender | Female/Male | 53/67 | 44.2/55.8 |
Serum ferritin (ng/ml) | ≤ 322/>322 | 47/73 | 39.2/60.8 |
CA19-9 (KU/L) | ≤ 35/>35 | 27/93 | 22.5/77.5 |
CA125 (KU/L) | ≤ 35/>35 | 98/22 | 81.7/18.3 |
CEA (ng/ml) | ≤ 5/>5 | 94/26 | 78.3/21.7 |
PA (mg/L) | ≤ 180/>180 | 54/66 | 45.0/55.0 |
ALB (g/L) | ≤ 35/>35 | 35/85 | 29.2/70.8 |
Tbil (µmol/L) | ≤ 26/>26 | 41/79 | 34.2/65.8 |
Ki-67 (%) | ≤ 30/>30 | 64/56 | 53.3/46.7 |
CD34/31 | No/Yes | 79/41 | 65.8/34.2 |
NLR | ≤ 3.5/>3.5 | 72/48 | 60.0/40.0 |
LMR | ≤ 4.0/>4.0 | 86/34 | 71.7/28.3 |
PLR | ≤ 138.5/>138.5 | 36/84 | 30.0/70.0 |
Lymphatic metastasis | N0/N1-2/Nx | 57/33/28 | 48.3/28.0/23.7 |
Vascular invasion | No/Yes | 74/46 | 61.7/38.3 |
Differentiated degree | Low | 8 | 6.7 |
Low-medium | 62 | 52.1 | |
Medium | 26 | 21.8 | |
Medium-high | 17 | 14.3 | |
High | 6 | 5.1 | |
Postoperative adjuvant therapy | No/Yes | 62/58 | 51.7/48.3 |
